# Bupivacaine Hydrochloride Injection: FDA shortage status > FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice. - Derived status: current - Source statuses: Current, To Be Discontinued - FDA package records: 61 - Latest FDA row update: 08/18/2026 - Retrieved: 2026-08-22T15:54:11+00:00 ## FDA package and manufacturer records - Aspiro Pharma Limited — Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 31722-275-32) — FDA availability: Available — updated: 07/17/2026 - Aspiro Pharma Limited — Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 31722-275-34) — FDA availability: Available — updated: 07/17/2026 - Aspiro Pharma Limited — Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 31722-276-32) — FDA availability: Available — updated: 07/17/2026 - Aspiro Pharma Limited — Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 31722-276-34) — FDA availability: Available — updated: 07/17/2026 - Aspiro Pharma Limited — Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 31722-277-32) — FDA availability: Available — updated: 07/17/2026 - Aspiro Pharma Limited — Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 31722-277-34) — FDA availability: Available — updated: 07/17/2026 - Eugia US LLC — Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-167-10) — FDA availability: Available — updated: 08/06/2026 - Eugia US LLC — Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-168-30) — FDA availability: Available — updated: 08/06/2026 - Eugia US LLC — Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-249-50) — FDA availability: Available — updated: 08/06/2026 - Eugia US LLC — Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-169-10) — FDA availability: Available — updated: 08/06/2026 - Eugia US LLC — Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-170-30) — FDA availability: Available — updated: 08/06/2026 - Eugia US LLC — Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-250-50) — FDA availability: Available — updated: 08/06/2026 - Eugia US LLC — Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-171-10) — FDA availability: Available — updated: 08/06/2026 - Eugia US LLC — Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-172-30) — FDA availability: Available — updated: 08/06/2026 - Fresenius Kabi USA, LLC — Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-17) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-31) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-37) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-465-57) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-17) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-31) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-37) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-467-57) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Sensorcaine, Injection, 7.5 mg/1 mL (NDC 63323-472-17) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Sensorcaine, Injection, 7.5 mg/1 mL (NDC 63323-472-37) — FDA availability: Available — updated: 08/04/2026 - Hospira, Inc., a Pfizer Company — Bupivacaine Hydrochloride, Injection, 0.25%; 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1159-10) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Bupivacaine Hydrochloride, Injection, 125 mg/50 mL (2.5 mg/mL) (NDC 0409-1160-01) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Bupivacaine Hydrochloride, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-1162-02) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Bupivacaine Hydrochloride, Injection, 225 mg/30 mL (7.5 mg/mL) (NDC 0409-1165-02) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Bupivacaine Hydrochloride, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-1159-01) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Bupivacaine Hydrochloride, Injection, 250 mg/50 mL (5 mg/mL) (NDC 0409-1163-01) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Bupivacaine Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-1162-01) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 0409-1165-01) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Bupivacaine Hydrochloride, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1159-02) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Bupivacaine Hydrochloride, Injection, Bupivacaine Spinal 15 mg/2 mL (7.5 mg/mL in 8.25% dextrose) (NDC 0409-3613-01) — FDA availability: Limited Availability — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Marcaine, Injection, 0.75% 15 mg/2 mL (7.5 mg/mL) in Dextrose 8.25% (NDC 0409-1761-10) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Marcaine, Injection, 0.75% 15 mg/2 mL (NDC 0409-1761-62) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Marcaine, Injection, Marcaine 125 mg/50 mL (2.5 mg/mL) (NDC 0409-1160-01) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Marcaine, Injection, Marcaine 150 mg/30 mL (5 mg/mL) (NDC 0409-1560-29) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Marcaine, Injection, Marcaine 225 mg/30 mL (7.5 mg/mL) (NDC 0409-2253-01) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Marcaine, Injection, Marcaine 25 mg/10 mL (2.5 mg/mL) (NDC 0409-1559-10) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Marcaine, Injection, Marcaine 50 mg/10 mL (5 mg/mL) (NDC 0409-1560-10) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Marcaine, Injection, Marcaine 75 mg/10 mL (7.5 mg/mL) (NDC 0409-1165-01) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Marcaine, Injection, Marcaine 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1559-30) — FDA availability: Available — updated: 08/07/2026 - Huons Co., Ltd — Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 73293-0002-2) — FDA availability: Unavailable — updated: 07/30/2026 - Kindos Pharmaceuticals Co. Ltd. — Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-722-32) — FDA availability: Not stated — updated: 05/05/2026 - Kindos Pharmaceuticals Co. Ltd. — Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-722-32) — FDA availability: Limited Availability — updated: 05/05/2026 - Kindos Pharmaceuticals Co. Ltd. — Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-723-52) — FDA availability: Not stated — updated: 05/05/2026 - Kindos Pharmaceuticals Co. Ltd. — Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-723-52) — FDA availability: Limited Availability — updated: 05/05/2026 - Kindos Pharmaceuticals Co. Ltd. — Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-725-32) — FDA availability: Not stated — updated: 05/05/2026 - Kindos Pharmaceuticals Co. Ltd. — Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-725-32) — FDA availability: Limited Availability — updated: 05/05/2026 - Kindos Pharmaceuticals Co. Ltd. — Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-726-52) — FDA availability: Not stated — updated: 05/05/2026 - Kindos Pharmaceuticals Co. Ltd. — Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-726-52) — FDA availability: Limited Availability — updated: 05/05/2026 - Kindos Pharmaceuticals Co. Ltd. — Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 71288-728-32) — FDA availability: Not stated — updated: 05/05/2026 - Kindos Pharmaceuticals Co. Ltd. — Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 71288-728-32) — FDA availability: Limited Availability — updated: 05/05/2026 - ONESOURCE SPECIALTY PTE LTD — Bupivacaine Hydrochloride PRESERVATIVE FREE, Injection, 2.5 mg/1 mL (NDC 72266-263-10) — FDA availability: Available — updated: 08/18/2026 - Somerset Therapeutics, LLC — Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-01) — FDA availability: Available — updated: 07/20/2026 - Somerset Therapeutics, LLC — Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-10) — FDA availability: Available — updated: 07/20/2026 - Somerset Therapeutics, LLC — Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-25) — FDA availability: Available — updated: 07/20/2026 - Somerset Therapeutics, LLC — Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-01) — FDA availability: Available — updated: 07/20/2026 - Somerset Therapeutics, LLC — Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-10) — FDA availability: Available — updated: 07/20/2026 - Somerset Therapeutics, LLC — Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-25) — FDA availability: Available — updated: 07/20/2026 ## Sources and formats - [FDA openFDA source](https://api.fda.gov/drug/shortages.json) - [Canonical HTML](https://citefacts.com/shortages/bupivacaine-hydrochloride-injection) - [JSON record](https://citefacts.com/shortages/bupivacaine-hydrochloride-injection.json)